Clal Insurance Enterprises Holdings LTD Eloxx Pharmaceuticals, Inc. Transaction History

Clal Insurance Enterprises Holdings LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$0.1 - $8.4 $57,037 - $4.79 Million	-570,374 Reduced 97.5%	14,626 $27,000
Q1 2020 Aug 14, 2020	BUY	$1.96 - $7.96 $1.14 Million - $4.65 Million	583,853 Added 50902.62%	585,000 $1.15 Million
Q1 2020 May 15, 2020	SELL	$1.96 - $7.96 $6,191 - $25,145	-3,159 Reduced 73.36%	1,147 $2,000
Q4 2019 Feb 13, 2020	SELL	$3.19 - $7.56 $1.85 Million - $4.39 Million	-580,694 Reduced 99.26%	4,306 $31,000
Q3 2019 Nov 12, 2019	SELL	$4.37 - $9.91 $43,700 - $99,100	-10,000 Reduced 1.68%	585,000 $2.64 Million
Q2 2019 Aug 13, 2019	BUY	$8.77 - $12.49 $5.22 Million - $7.43 Million	595,000 New	595,000 $5.93 Million

Ticker ELOX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,656,200
Description
Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing ribosome modulation for the treatment of rare and ultra-rare premature stop codon diseases. Its lead investigational drug product candidate is ELX-02, which is in Phase 2 clinical trial for the treatment of cystic fibrosis and nephropathic cystinosis p...

Get notified when there are updates to the investment portfolio of Clal Insurance Enterprises Holdings LTD, based on Form 13F filings with the SEC.

Stay updated on Clal Insurance Enterprises Holdings LTD with notifications on news.